|
End-of-day quote
Shanghai S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 18.98 CNY | +1.55% |
|
+0.80% | -8.35% |
| 08-12 | Lingrui Pharmaceutical H1 Profit Up 4.4%; Shares Fall 9% | MT |
| 08-11 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 10.76B 1.61B 1.43B 1.33B 1.21B 2.29B 155B 2.31B 16.11B 6.25B 78.86B 6.03B 5.9B 253B | P/E 2026 * |
12.9x | P/E 2027 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 10.64B 1.59B 1.41B 1.31B 1.2B 2.26B 153B 2.28B 15.93B 6.18B 77.98B 5.96B 5.83B 250B | EV / Sales 2026 * |
2.64x | EV / Sales 2027 * | 2.41x |
| Free-Float |
75.98% | Yield 2026 * |
6.32% | Yield 2027 * | 6.85% |
| 1 day | +1.55% | ||
| 1 week | +0.80% | ||
| 1 month | -3.21% | ||
| 3 months | -8.44% | ||
| 6 months | -13.69% | ||
| Current year | -8.35% |
| 1 week | 18.57 |  | 18.99 |
| 1 month | 18.51 | | 19.67 |
| Current year | 18.51 | | 23.65 |
| 1 year | 18.51 | | 23.65 |
| 3 years | 15.41 | | 27.26 |
| 5 years | 9.73 | | 27.26 |
| 10 years | 6.81 | | 27.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 42 | 06/06/2014 |
Peng Yu
DFI | Director of Finance/CFO | 57 | 06/06/2020 |
Yan Chen
PRN | Corporate Officer/Principal | 54 | 08/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Yu
BRD | Director/Board Member | 57 | - |
Wei Xiong
CHM | Chairman | 42 | 29/04/2019 |
Guo Xin Feng
BRD | Director/Board Member | 37 | 06/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/01/25 | Buy | 150,000 | 0.0265% | |||
| 10/01/25 | Buy | 150,000 | 0.0265% | |||
| 10/01/25 | Buy | Director | 150,000 | 0.0265% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.55% | +0.80% | -13.41% | +5.97% | 1.61B | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -0.53% | -3.10% | +22.12% | +52.60% | 369.88B | |
| Weighted average by Cap. | -0.60% | -3.32% | +29.05% | +69.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.03B 602M 535M 498M 454M 857M 57.95B 865M 6.04B 2.34B 29.56B 2.26B 2.21B 94.93B | 4.36B 651M 578M 539M 491M 927M 62.66B 936M 6.53B 2.53B 31.96B 2.44B 2.39B 103B |
| Net income | 830M 124M 110M 102M 93.4M 176M 11.92B 178M 1.24B 482M 6.08B 465M 454M 19.52B | 894M 133M 118M 110M 101M 190M 12.84B 192M 1.34B 519M 6.55B 501M 490M 21.04B |
| Net Debt | -120M -17.9M -15.9M -14.82M -13.51M -25.5M -1.72B -25.74M -180M -69.7M -879M -67.2M -65.74M -2.82B | -266M -39.68M -35.24M -32.85M -29.95M -56.53M -3.82B -57.05M -398M -154M -1.95B -149M -146M -6.26B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CN¥18.98 | +1.55% | 4,436,335 |
| 29/09/26 | CN¥18.69 | +0.27% | 2,533,663 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600285 Stock
Select your edition
All financial news and data tailored to specific country editions
